Expression of CD9 and CD82 in clear cell renal cell carcinoma and its clinical significance

Pathology Research and Practice

Volumn 210, Issue 5, 2014, Pages 285-290

  Kwon, Hyeong Ju ^a   Min, Sun Young ^a   Park, Min Jee ^a   Lee, Cheol ^a   Park, Jeong Hwan ^a   Chae, Ji Youn ^a   Moon, Kyung Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

CD82; CD9; Clear cell renal cell carcinoma; Prognosis

Indexed keywords

CD82 ANTIGEN; CD9 ANTIGEN; CD82 PROTEIN, HUMAN; CD9 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR CELL; TUMOR VOLUME; CELL MOTION; DISEASE FREE SURVIVAL; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD82; ANTIGENS, CD9; CARCINOMA, RENAL CELL; CELL MOVEMENT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84898058665     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.01.004     Document Type: Article

References (24)

1. Ljungberg B., Campbell S.C., Choi H.Y., Jacqmin D., Lee J.E., Weikert S., Kiemeney L.A. The epidemiology of renal cell carcinoma. European Urology 2011, 60:615-621.
2. Prasad S.R., Humphrey P.A., Catena J.R., Narra V.R., Srigley J.R., Cortez A.D., Dalrymple N.C., Chintapalli K.N. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics: A Review Publication of the Radiological Society of North America Inc 2006, 26:1795-1806. (discussion 1806-1710).
3. Yoo S.H., Lee K., Chae J.Y., Moon K.C. CD151 expression can predict cancer progression in clear cell renal cell carcinoma. Histopathology 2011, 58:191-197.
4. Boucheix C., Rubinstein E. Tetraspanins, cellular and molecular life sciences. Cellular and Molecular Life Sciences 2001, 58:1189-1205.
5. Lazo P.A. Functional implications of tetraspanin proteins in cancer biology. Cancer Science 2007, 98:1666-1677.
6. Boucheix C., Duc G.H., Jasmin C., Rubinstein E. Tetraspanins and malignancy. Expert Reviews in Molecular Medicine 2001, 1-17.
7. Chen Z., Mustafa T., Trojanowicz B., Brauckhoff M., Gimm O., Schmutzler C., Kohrle J., Holzhausen H.J., Kehlen A., Klonisch T., Finke R., Dralle H., Hoang-Vu C. CD82, and CD63 in thyroid cancer. International Journal of Molecular Medicine 2004, 14:517-527.
8. Protzel C., Kakies C., Kleist B., Poetsch M., Giebel J. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma. Virchows Archiv: An International Journal of Pathology 2008, 452:369-375.
9. Kuroda N., Inoue K., Guo L., Miyazaki E., Hayashi Y., Naruse K., Toi M., Hiroi M., Shuin T., Enzan H. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas. Human Pathology 2001, 32:1071-1077.
10. Kauffman E.C., Barocas D.A., Chen Y.T., Yang X.J., Scherr D.S., Tu J.J. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes. Journal of Urology 2009, 181:2305-2311.
11. Fuhrman S.A., Lasky L.C., Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. American Journal of Surgical Pathology 1982, 6:655-663.
12. Hemler M.E. Tetraspanin functions and associated microdomains. Nature Reviews Molecular Cell Biology 2005, 6:801-811.
13. Higashiyama M., Taki T., Ieki Y., Adachi M., Huang C.L., Koh T., Kodama K., Doi O., Miyake M. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Research 1995, 55:6040-6044.
14. Wang J.C., Begin L.R., Berube N.G., Chevalier S., Aprikian A.G., Gourdeau H., Chevrette M. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2007, 13:2354-2361.
15. Hori H., Yano S., Koufuji K., Takeda J., Shirouzu K. CD9 expression in gastric cancer and its significance. Journal of Surgical Research 2004, 117:208-215.
16. Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nature Reviews. Cancer 2009, 9:40-55.
17. Wang H.X., Li Q., Sharma C., Knoblich K., Hemler M.E. Tetraspanin protein contributions to cancer. Biochemical Society Transactions 2011, 39:547-552.
18. Dong J.T., Lamb P.W., Rinker-Schaeffer C.W., Vukanovic J., Ichikawa T., Isaacs J.T., Barrett J.C. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995, 268:884-886.
19. Tonoli H., Barrett J.C. CD82 metastasis suppressor gene: a potential target for new therapeutics?. Trends in Molecular Medicine 2005, 11:563-570.
20. Son B.H., Choi J.S., Lee J.H. Prognostic values of KAI1 and survivin expression in an infiltrating ductal carcinoma of the breast. Pathology 2005, 37:131-136.
21. Yang X., Wei L.L., Tang C., Slack R., Mueller S., Lippman M.E. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Research 2001, 61:5284-5288.
22. Abe M., Sugiura T., Takahashi M., Ishii K., Shimoda M., Shirasuna K. A novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells. Cancer Letters 2008, 266:163-170.
23. Yanez-Mo M., Barreiro O., Gordon-Alonso M., Sala-Valdes M., Sanchez-Madrid F. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends in Cell Biology 2009, 19:434-446.
24. Li M.Q., Hou X.F., Shao J., Tang C.L., Li D.J. The DSCs-expressed CD82 controls the invasiveness of trophoblast cells via integrinbeta1/MAPK/MAPK3/1 signaling pathway in human first-trimester pregnancy. Biology of Reproduction 2010, 82:968-979.